Literature DB >> 4950030

Clinical control in shock.

G Walters.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4950030      PMCID: PMC1519966          DOI: 10.1136/jcp.s3-4.1.32

Source DB:  PubMed          Journal:  J Clin Pathol Suppl (R Coll Pathol)        ISSN: 0144-0330


× No keyword cloud information.
  12 in total

1.  THE USAGE OF DIBENZYLINE IN CLINICAL SHOCK.

Authors:  R F WILSON; D V JABLONSKI; A P THAL
Journal:  Surgery       Date:  1964-07       Impact factor: 3.982

2.  SIGNIFICANCE OF OLIGEMIA IN HYPOTENSIVE SURGICAL PATIENTS.

Authors:  G WALTERS; G K MCGOWAN
Journal:  Lancet       Date:  1965-06-12       Impact factor: 79.321

3.  Blood volume.

Authors:  M I GREGERSEN; R A RAWSON
Journal:  Physiol Rev       Date:  1959-04       Impact factor: 37.312

4.  Refractory hypotension in man--is this irreversible shock?

Authors:  L L SMITH; F D MOORE
Journal:  N Engl J Med       Date:  1962-10-11       Impact factor: 91.245

5.  Studies of blood volume and transfusion therapy in the Korean battle casualty.

Authors:  T C PRENTICE; J M OLNEY; C P ARTZ; J M HOWARD
Journal:  Surg Gynecol Obstet       Date:  1954-11

6.  Cardiovascular, renal, and general effects of large, rapid plasma infusions in convalescent men.

Authors:  J R WILSON; C R HARRISON
Journal:  J Clin Invest       Date:  1950-02       Impact factor: 14.808

7.  Pulmonary oedema in bacterial shock.

Authors:  J F Riordan; G Walters
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

8.  The significance of central venous pressure and cardiac output measurements in shock.

Authors:  J F Riordan; G Walters; W D McLay
Journal:  Postgrad Med J       Date:  1969-08       Impact factor: 2.401

9.  An examination of single-tracer, semi-automated blood volume methodology.

Authors:  M L Heath; M D Vickers
Journal:  Anaesthesia       Date:  1968-10       Impact factor: 6.955

10.  Phenoxybenzamine in septic shock.

Authors:  R W Anderson; P M James; C E Bredenberg; R M Hardaway
Journal:  Ann Surg       Date:  1967-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.